TipRanks
JBT Marel (MX:JBTM)
:JBTM
Mexico Market
EarningsQ2 2026 Earnings Report

JBT Marel (JBTM) Q2 2026 Earnings Report

0 Followers

MX:JBTM Q2 2026 EPS Results

Actual EPS$34.23
Consensus EPS$35.42
Beat/MissMissed by -$1.19
One Year Ago EPS$26.15

MX:JBTM Q2 2026 Revenue Results

Actual Revenue$17.20B
Expected Revenue$17.35B
Beat/MissMissed by -$147.96M
YoY Revenue Growth+4.99%

Earnings Announcement Details

QuarterQ2 2026
Date08/03/2026
TimeAfter Close
Conference CallMonday, August 3, 2026
MX:JBTM Upcoming Earnings
JBT Marel's next earnings date is estimated for November 2, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

MX:JBTM Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 03, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized strong demand, record backlog and material progress on synergies and footprint optimization, with solid cash generation and protein-led revenue growth. However, short-term execution challenges — notably in Prepared Food & Beverage equipment shipments, logistics and costs — caused a Q2 revenue/margin shortfall and required restructuring actions (AGV and facility moves) that will create temporary disruption. Management expects these actions to improve margins and efficiency into the back half of 2026 and through 2027, maintaining full-year guidance while projecting meaningful future savings and a path to higher adjusted EBITDA margins by 2028.
Company Guidance
Management guided Q3 2026 to 2–4% organic revenue growth (partially offset by ~1% FX) and adjusted EBITDA margins of 17.0–17.5%, and maintained full‑year 2026 guidance (midpoint implying ~6% consolidated revenue growth and a 145‑bp expansion in adjusted EBITDA margin), citing record backlog with visibility to >90% of back‑half equipment revenue and an expected steeper Q4 ramp versus Q3. They said about $20M of Q2 revenue was delayed into the back half (roughly a $5–6M EBITDA impact assuming ~25–30% flow‑through), expect PFB margins to improve ~25–50 bps in Q3 and another ~100 bps into Q4, and highlighted cost actions supporting the outlook: AGV restructuring (~$9M annual savings, including ~$3M in H2 2026) and footprint optimization (≈1.3M sq ft / ~15% reduction delivering $25–30M annualized savings by 2028, with $4–5M embedded in 2026); they also refined adjusted‑EPS assumptions and reiterated a 20% adjusted EBITDA margin target for 2028.
Orders Growth and Scale
Orders increased 10% year-over-year and marked the third consecutive quarter with orders exceeding $1 billion, underscoring strong demand and the strategic benefits of the JBT Marel combination.
Consolidated Revenue Increase
Second quarter consolidated revenue was $981 million, up 5% year-over-year (3% organic growth, 2% from foreign exchange).
Protein Segment Outperformance
Protein Solutions revenue of $467 million grew 11% year-over-year (8% organic, 3% FX). Protein adjusted EBITDA margin was ~24% in Q2 (with ~200 basis points contribution from tariff refunds), driven by volume leverage in poultry and synergy/continuous improvement benefits.
Strong Backlog and Revenue Visibility
Record backlog with visibility to over 90% of back-half equipment revenue, supporting the company’s maintained full-year 2026 guidance and confidence in second-half performance.
Synergies and Cross-Selling Progress
Synergy orders of $45 million realized in the first 6 months and $75 million over the last 18 months; cross-selling examples include multiline orders for integrated prepared poultry solutions leveraging the combined portfolio.
Footprint Optimization and Cost Savings Upside
Announced ~1.3 million square feet of facility consolidations (~15% reduction in global footprint). Expected annualized savings of ~$25 million–$30 million by 2028 (above prior $10M–$15M estimate), with $4M–$5M embedded in the 2026 forecast.
Warehouse Automation (AGV) Restructuring Savings
Restructuring of the warehouse automation business to standardize products and consolidate facilities is expected to generate ~$9 million of annual savings, including ~$3 million in H2 2026.
Strong Cash Generation and Leverage Target Met
Generated $179 million year-to-date free cash flow (conversion to adjusted EBITDA of 58%). Leverage at quarter-end just below 2.5x, now within the target 2.0x–2.5x range ~18 months after close.
Maintained Full-Year Guidance and Q3 Outlook
Management maintained full-year 2026 guidance: midpoint reflects consolidated revenue growth of 6% and adjusted EBITDA margin expansion of 145 basis points. Q3 guide: organic revenue growth of 2%–4% (net ~1% FX headwind) and adjusted EBITDA margin of 17%–17.5%.
Capital Allocation Action
Announced a $200 million share buyback program and signaled opportunistic approach between buybacks and debt paydown while prioritizing integration.

MX:JBTM Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 02, 2026
2026 (Q3)
36.79 / -
34.053―
2026 (Q2)
35.42 / 34.23
26.15430.87% (+8.07)
2026 (Q1)
25.98 / 27.73
17.02762.89% (+10.71)
2025 (Q4)
33.42 / 34.76
29.8416.47% (+4.91)
2025 (Q3)
26.42 / 34.05
26.3329.33% (+7.72)
2025 (Q2)
22.49 / 26.15
18.43141.90% (+7.72)
2025 (Q1)
14.76 / 17.03
14.9214.12% (+2.11)
2024 (Q4)
31.82 / 29.84
24.57421.43% (+5.27)
2024 (Q3)
24.66 / 26.33
19.48435.14% (+6.85)
2024 (Q2)
21.84 / 18.43
17.0278.25% (+1.40)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed